dihydroisotanshinone i has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, YC; Lee, IY; Lin, CL; Lin, WY; Lin, YS; Lin, YY; Shu, LH; Wu, CY; Yang, YH | 1 |
| Chen, YJ; Cheng, YC; Kang, HY; Kuan, FC; Lee, KD; Lin, WY; Lin, YS; Lin, YY; Lu, MC; Shu, LH; Tsai, MY; Wu, CY; Yang, JJ; Yang, YH | 1 |
2 other study(ies) available for dihydroisotanshinone i and Cancer of Prostate
| Article | Year |
|---|---|
Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway.
Topics: Antineoplastic Agents; Cell Line; Cell Movement; Chemokine CCL2; Combined Modality Therapy; DNA Damage; Gamma Rays; Humans; Male; Phenanthrenes; Prostatic Neoplasms; Radiation-Sensitizing Agents | 2018 |
Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway.
Topics: Animals; Cell Line, Tumor; Cell Movement; Chemokine CCL2; Coculture Techniques; Drugs, Chinese Herbal; Humans; Macrophages; Male; Medicine, Chinese Traditional; Mice; Phenanthrenes; Prostate; Prostatic Neoplasms; Protein Transport; rhoA GTP-Binding Protein; Salvia miltiorrhiza; Snail Family Transcription Factors; STAT3 Transcription Factor; Treatment Outcome | 2017 |